19:HKEXRimbaco Group Global Limited Analysis
Data as of 2026-09-05 - not real-time
₩42,050.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At KRW 42,050.00, HK inno.N Corporation shows no decisive moving-average alignment, leaving the trend neutral. It has gained 8.4% over the past 30 days. RSI sits at 51.1, which reads as neutral, and MACD momentum is bearish. Watch KRW 39,550.00 as support and KRW 44,650.00 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 10.5 sits below the sector average of 30.6. Consensus targets land 54.4% above where the shares trade now. Revenue is growing at 5.1% on a 5.3% profit margin. The 0.98% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 46.9%, a beta of 0.92 and a maximum drawdown of 39.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Valuation screens as undervalued: a P/E of 10.5 sits below the sector average of 30.6. Consensus targets land 54.4% above where the shares trade now. Revenue is growing at 5.1% on a 5.3% profit margin. The 0.98% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 46.9%, a beta of 0.92 and a maximum drawdown of 39.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 47509.75
- MACD momentum is negative
- 30-day price change of +8.4%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 10.5 versus sector average of 30.6
- Trading below the 200-day average of 47509.75
- Analyst targets imply +54.4% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 10.5 versus sector average of 30.6
- Analyst targets imply +54.4% versus the current price
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth5.10%
Profit Margin5.34%
P/E Ratio10.5
ROE3.90%
ROA2.11%
Debt/Equity39.75
Op. Cash Flow₩42.6B
Free Cash Flow₩-6628940800
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI51.1
Support₩39,550.00
Resistance₩44,650.00
MA 20₩42,400.00
MA 50₩40,444.00
MA 200₩47,509.75
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48
Valuation
Fair Value₩5,151.57
Target Price₩64,916.67
Upside/Downside54.38%
GradeUndervalued
TypeBlend
Dividend Yield0.98%
Risk Assessment
Beta0.92
Volatility46.91%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.